CUBRC’s Biological and Medical Sciences Group serves the National Institutes of Health, the National Institute of Allergy and Infectious Disease, the Biological Advanced Research and Development Authority and the Department of Defense to integrate drug development activities from discovery through advanced stages. CUBRC partners with early and mid-stage pharmaceutical companies and offers a world-class scientific team having expertise in drug development and proven experience with Federal procurement processes to serve as a systems integrator for medical countermeasure development programs.
CUBRC’s scientific team fully engages with our partners to understand the complexity of the medical technology under development. We apply our capabilities and expertise to complement those of our partners to develop strategies and match technologies to government agencies’ requirements. We work closely with our partners to engage potential customers and prepare fully responsive and compliant proposals. Our extensive experience managing complex government-funded pharmaceutical development programs reduces risk for our customers and increases the probability of award and execution of a contract or grant – helping to cost-effectively accelerate the advancement of the technology for our partners and customers.
Our programs are aimed at the development of treatments for use against public health indications as well as for those associated with the use of biological, chemical or radiological weapons.